Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Theophylline × Breast × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 2 Other hematologic neoplasm 2 Lymphoid 1 Genitourinary 1 Breast 1

Conditions

Triple Negative Breast Neoplasms 1

Interventions

Trastuzumab 585 Paclitaxel 569 Cyclophosphamide 539 Docetaxel 482 Capecitabine 412 Letrozole 343 Carboplatin 322 Fulvestrant 314 Doxorubicin 280 Tamoxifen 244 pembrolizumab 226 Anastrozole 208 Epirubicin 205 exemestane 195 Radiotherapy 189 Bevacizumab 182 pertuzumab 180 Gemcitabine 175 Vinorelbine 162 Lapatinib 156 palbociclib 145 130-nm albumin-bound paclitaxel 140 Magnetic Resonance Spectroscopy 133 Albumin-Bound Paclitaxel 129 eribulin 124 Exercise 123 Fluorouracil 111 Taxes 108 Cisplatin 99 Everolimus 97

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05076682 2025-12-03

Renaissance

Fudan University

Phase 2 Recruiting

Triple Negative Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡